(via NewsDirect)
Contact Details
+61 413 713 744
jonathan@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 AUD | 0.00% |
|
0.00% | -48.57% |
22/05 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
20/05 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
(via NewsDirect)
+61 413 713 744
jonathan@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source
1st Jan change | Capi. | |
---|---|---|
-48.57% | 1.03Cr | |
+17.12% | 12TCr | |
+20.77% | 12TCr | |
+20.90% | 2.66TCr | |
-22.58% | 1.99TCr | |
-17.17% | 1.63TCr | |
-44.74% | 1.55TCr | |
-19.31% | 1.55TCr | |
+59.48% | 1.48TCr | |
+2.19% | 1.37TCr |